PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,734,844 | -23.4% | 154,330 | 0.0% | 0.10% | -19.5% |
| Q2 2023 | $6,184,003 | -1.9% | 154,330 | -0.0% | 0.12% | -7.8% |
| Q1 2023 | $6,301,064 | +14.4% | 154,400 | +8.2% | 0.13% | +8.5% |
| Q4 2022 | $5,510,033 | -27.4% | 142,710 | 0.0% | 0.12% | -32.2% |
| Q3 2022 | $7,591,000 | -8.8% | 142,710 | 0.0% | 0.17% | -4.4% |
| Q2 2022 | $8,320,000 | -23.5% | 142,710 | +0.1% | 0.18% | -6.2% |
| Q1 2022 | $10,876,000 | +26.8% | 142,505 | 0.0% | 0.19% | +38.6% |
| Q4 2021 | $8,575,000 | +22.2% | 142,505 | +13.7% | 0.14% | +12.9% |
| Q3 2021 | $7,020,000 | +0.3% | 125,350 | +8.7% | 0.12% | +0.8% |
| Q2 2021 | $6,999,000 | -6.2% | 115,335 | +8.4% | 0.12% | -11.5% |
| Q1 2021 | $7,460,000 | +17.1% | 106,440 | -0.0% | 0.14% | +14.9% |
| Q4 2020 | $6,372,000 | – | 106,490 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |